Orion Infusion Statistics

Total Valuation

Orion Infusion has a market cap or net worth of BDT 8.06 billion. The enterprise value is 8.37 billion.

Market Cap	8.06B
Enterprise Value	8.37B

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	Dec 5, 2024

Share Statistics

Orion Infusion has 20.36 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	20.36M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 193.80.

PE Ratio	193.80
Forward PE	n/a
PS Ratio	10.30
PB Ratio	25.83
P/TBV Ratio	25.83
P/FCF Ratio	211.58
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 80.07, with an EV/FCF ratio of 219.52.

EV / Earnings	201.07
EV / Sales	10.69
EV / EBITDA	80.07
EV / EBIT	96.63
EV / FCF	219.52

Financial Position

The company has a current ratio of 0.91, with a Debt / Equity ratio of 1.03.

Current Ratio	0.91
Quick Ratio	0.30
Debt / Equity	1.03
Debt / EBITDA	3.08
Debt / FCF	8.45
Interest Coverage	2.33

Financial Efficiency

Return on equity (ROE) is 13.69% and return on invested capital (ROIC) is 8.51%.

Return on Equity (ROE)	13.69%
Return on Assets (ROA)	6.47%
Return on Invested Capital (ROIC)	8.51%
Return on Capital Employed (ROCE)	25.56%
Revenue Per Employee	1.09M
Profits Per Employee	57,943
Employee Count	718
Asset Turnover	0.94
Inventory Turnover	3.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.01% in the last 52 weeks. The beta is -2.23, so Orion Infusion's price volatility has been lower than the market average.

Beta (5Y)	-2.23
52-Week Price Change	-29.01%
50-Day Moving Average	384.73
200-Day Moving Average	385.05
Relative Strength Index (RSI)	52.30
Average Volume (20 Days)	374,245

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Infusion had revenue of BDT 782.52 million and earned 41.60 million in profits. Earnings per share was 2.04.

Revenue	782.52M
Gross Profit	321.89M
Operating Income	86.57M
Pretax Income	49.26M
Net Income	41.60M
EBITDA	97.11M
EBIT	86.57M
Earnings Per Share (EPS)	2.04

Full Income Statement

Balance Sheet

The company has 12.85 million in cash and 321.95 million in debt, giving a net cash position of -302.73 million or -14.87 per share.

Cash & Cash Equivalents	12.85M
Total Debt	321.95M
Net Cash	-302.73M
Net Cash Per Share	-14.87
Equity (Book Value)	312.08M
Book Value Per Share	15.33
Working Capital	-46.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 45.31 million and capital expenditures -7.20 million, giving a free cash flow of 38.11 million.

Operating Cash Flow	45.31M
Capital Expenditures	-7.20M
Free Cash Flow	38.11M
FCF Per Share	1.87

Full Cash Flow Statement

Margins

Gross margin is 41.14%, with operating and profit margins of 11.06% and 5.32%.

Gross Margin	41.14%
Operating Margin	11.06%
Pretax Margin	6.29%
Profit Margin	5.32%
EBITDA Margin	12.41%
EBIT Margin	11.06%
FCF Margin	4.87%

Dividends & Yields

This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 0.32%.

Dividend Per Share	1.20
Dividend Yield	0.32%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	1
Payout Ratio	42.92%
Buyback Yield	n/a
Shareholder Yield	0.32%
Earnings Yield	0.52%
FCF Yield	0.47%

Dividend Details

Stock Splits

The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.

Last Split Date	Dec 4, 2011
Split Type	Forward
Split Ratio	10

Scores

Orion Infusion has an Altman Z-Score of 11.76.

Altman Z-Score	11.76
Piotroski F-Score	n/a